Why the Pangea project ?
To educate and raise awareness for stakeholders (prescribing physicians, government agencies, hospital administrators, etc.) on the benefits of nuclear medicine worldwide.
The Pangea project promotes current and future nuclear medicine for better practices when it comes to tests, diagnoses, and therapies.
Our objectives with regard to the promotion of nuclear medicine :
- To outreached proactively and consistently to the
stakeholders. - To make nuclear medicine better know on a global scale.
- Educate medical profesionnal, outside nuclear medicine on the benefit
of the use of medical isotopes to diagnose and treat diseases
The purpose of the Pangea project
To create a complete web platform for patients and non nuclear medical professionals
-Specialized content , information on the industry, ePatient magazine.
Educate health professionals (specifically prescribing physicians) on the safe use of medical isotopes for diagnostic and therapeutic purposes.
Promote new technologies/tests available, new discoveries as well as the best techniques to use.
Free E-publication, the ePatient will inform you on current and
future diagnostic tests and therapies available on a global scale.
Co-Editor, Dr. François Lamoureux
Co-Editor, Dr. Jean-Luc Urbain
Collaborators : SNMMI, AOCNMB, ALASBIMN, EANM, CANM, ARSNM, ANZSNM, ASNC, AIPES
International-Educational-Platform
‘’One of the major wishes of the worldwide nuclear medicine community that we have heard over and over again is an international coordinated effort to educate people on nuclear medicine, Jean-Luc Urbain, past president CANM’’
Les acteurs du
projet Pangea
Co-Editor
Dr.Francois Lamoureux,
M.D, M.Sc., FRCP(C), ABNM, Président élu, CANM
Editorial board
Dr. Zvi Bar-Sever
M.D, Chair Pediatric Nuclear Medicine Council, EANM
Editorial board
Dr. Paige Bennett
M.D., Nuclear Medicine/Medical Imaging Specialist , Wake Forest University, USA
Editorial board
Dr. Salah-Eddine Bouyoucef
M.D., Ph.D., Chief Nuclear Medicine , CHU Bab El Oued, Alger, Algeria
Editorial board
Dr. Sanjay Gambhir
M.D., Ph.D., Chief/Chair, Nuclear Medicine, University of Lucknow, India
Editorial board
Dr. Bennett Greenspan
M.D., President of the SNMMI, USA
Editorial board
Dr. Jun Hatazawa
M.D., Ph.D., President of the AOFNMB, Japan
Editorial board
Dr. Wei He
M.D., Ph. D., Director of Nuclear Medicine and PET/CT, Center Fu Dan University, China
Editorial board
Dr. Fernando Mutt
M.D., Past President ALASBIMN, Uruguay
Editorial board
Dr. Raymond Russel
M.D., Ph.D.,Director, Nuclear Cardiology, Rhode Island Hospital & President, American Society of Nuclear Cardiology, USA
Editorial board
Dr. Einat Sapir
M.D., Ph.D., Head, Department of Nuclear Medicine Tel Aviv Sourasky Medical Center, Israel
Editorial board
Dr. Mike Sathekge
M.D.,ead of Nuclear Medicine Steve Biko Acade-mic Hospital & President, Colleges of Medicine of South Africa, South Africa
Editorial board
Dr. Jean-Philippe Vuillez
M.D.,Ph.D., Prof., Vice-Doyen Formation Directeur des études PU-PH – Médecine Nucléaire, France
Editorial board
Dr. Nadia Whithofs
M.D., Ph.D, Division of Nuclear Medicine and Oncological Imaging, CHU of Liege, Belgium
Editorial board
Dr. Akram Al-Ibraheem
M.D., President, Arab Society of Nuclear Medicine (ARSNM) Chairman, Department of Nuclear Medicine & PET/CT EANM, King Hussein Cancer Center, Amman, Jordan
Editorial board
Dr. Mohamad Haider
M.D.,Vice-President, Arab Society of Nuclear Medicine (ARSNM) Director, Nuclear Medicine Division and Cyclotron Facility American University of Beirut Medical Center, Beirut, Lebanon
Editorial
Dr. Rodrigo Jaimovich
M.D.,Past-President of ALASBIMN Professor, Nuclear Medicine at Clinica las Condes S.A Chili University, Chili
Editorial
Dr. Christian Sheiber
M.D., Professor and Chief of Nuclear Medicine, Hospitals de Lyon, France Ph.D.,
Editorial
Dr. Andrew Scott
M.D., President WFNMB, Australia
1600, Blv Henri-Bourassa O, Bureau 405, Montréal, QC, Canada, H3M3E2
Collaborateurs : SNMMI, AOCNMB, ALASBIMN, EANM, CANM, ARSNM, ANZSNM, ASNC, AIPES